Clinical Trial Update: Genotype-Driven Treatment of Advanced Non-small Cell Lung Cancer Based on mRNA Expression of ERCC1 & RRM1 as First-line Chemotherapy [Phase 2]

View source ↗

Summary

This Phase 2 trial in advanced non-small cell lung cancer investigates genotype-guided first-line chemotherapy based on ERCC1 and RRM1 mRNA expression. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Yonsei University | Conditions: Non-small Cell Lung Carcinoma | Phase 2 | Status: COMPLETED